[12] Metformin: Anchor in the GLP-1 RA Care Continuum Journey The mechanistic, real-world, clinical trials and pharmacovigilance evidence landscape suggests metformin as the potential anchor pharmacological agent across the entire GLP-1 RA care continuum, during therapy and beyond.Table 1 summarises the key potential outcome benefits at each phase
All these drugs are being used off-label to treat PCOS
But the agency released a public advisory on unauthorized injectable peptides in April warning that these products can be dangerous and cause hormonal imbalance, mood swings, blood sugar imbalance, liver or kidney damage, blood clots, and growth of cancerous tumours. The advisory encourages Canadians to only buy prescription drugs from licensed pharmacies and to check for a drugs eight-digit drug identification number to ensure its legal
Company and organization updates Ingredient supplier Sabinsa announced Brandon Prenger as director of business development
It is not approved by Health Canada as a medication, therapeutic agent, or consumer product when provided in research-grade form
Cadmium, environmental exposure, and health outcomes